GLP (Good Laboratory Practice)

GLP (Good Laboratory Practice) - Axcellant

GLP (Good Laboratory Practice)

  1. lut 28, 2025

What Does the 'GLP (Good Laboratory Practice)’ Mean?

GLP, or Good Laboratory Practice, refers to a quality system of management controls for research laboratories and organizations to ensure the uniformity, consistency, reliability, reproducibility, quality, and integrity of chemical and pharmaceutical non-clinical safety tests. It encompasses organizational processes and conditions under which laboratory studies are planned, performed, monitored, recorded, archived, and reported.

GLP standards were developed to promote the quality and validity of test data used for determining the safety of chemicals and chemical products. These practices are required by law in many countries for non-clinical animal studies that support or are intended to support applications for research or marketing permits for products regulated by government agencies.

Why Is the 'GLP (Good Laboratory Practice)’ Important in Clinical Research?

GLP is crucial in clinical research as it ensures the quality and integrity of non-clinical safety data used to support human clinical trials. By following GLP standards, researchers can provide regulators with reliable information to assess the safety of new drugs or medical devices before they are tested in humans.

Adherence to GLP principles also enhances the reproducibility of study results and facilitates international acceptance of data. This standardization helps streamline the drug development process, potentially reducing the time and cost associated with bringing new treatments to market while maintaining high safety standards.

Good Practices and Procedures

  1. Implement a comprehensive Standard Operating Procedures (SOP) system that covers all aspects of laboratory operations, from equipment maintenance to data handling.
  2. Establish a Quality Assurance Unit (QAU) responsible for conducting internal audits, reviewing study protocols, and ensuring compliance with GLP regulations.
  3. Develop and maintain a robust chain of custody system for test items, specimens, and data to ensure traceability throughout the study lifecycle.
  4. Implement a validated computerized system for data acquisition, processing, and storage that includes appropriate access controls and audit trails.
  5. Conduct regular staff training programs on GLP principles, ethical considerations, and current regulatory requirements to maintain a culture of compliance.

Related Terms

Resources

How ACT EU Is Forcing a Global Approach to Trial Timelines

Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…

Axcellant at ICNC Berlin: Following the Future of Nuclear Cardiology – and helping bring it to clinical reality

The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…

Axcellant Establishes Advisory Board to Strengthen Clinical and Strategic Leadership

Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…